HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Be aware of CMS coverage restrictions for off-label uses for anticancer drugs
• Will there be an oncologist shortage by 2020?
• Adding metformin to oral contraceptive may be beneficial for women with PCOS
• Adding radiation to hormone therapy improved survival in patients with prostate cancer
• Aspirin may be linked to lower risk for death in prostate cancer
• Chemotherapy plus radiation prevented bladder cancer recurrence
• Children with HIV responded suboptimally to novel adjuvanted influenza A (H1N1) vaccine
• Cisplatin with radiation benefited HPV–, p16–positive status in locally advanced head and neck cancer
• Crizotinib showed efficacy in lung cancer
• Do teaching hospitals still teach? Michael N. Needle, MD
• ECOG 2205: Trial stopped due to pulmonary toxicity in operable esophageal adenocarcinoma
• EPIC: C-reactive protein, interleukin 6, IL-1 receptor antagonist associated with endometrial cancer risk in obese patients
• Expert consensus document offers suggestions on concomitant PPI, antiplatelet drug use
• FDA approves everolimus to treat subependymal giant cell astrocytoma
• FDA rejects lorcaserin for weight-loss therapy
• Guideline updates use of erythropoiesis-stimulating agents
• Hospice care underutilized by men dying of prostate cancer
• KRAS mutation may be linked to varying colorectal cancer prognoses
• If you have patient contact, get vaccinated William Schaffner, MD
• Investigators identify signaling pathway that may affect pediatric osteosarcoma
• Know your patients’ use of complementary and alternative medicine in oncology
• Lobular involution, mammographic breast density associated with breast cancer incidence
• Lower testosterone levels associated with poor quality of life, sexual function
• Measles eradication effort may be affected by HIV
• Non-invasive stereotactic radiation comparable to surgery for NSCLC
• Omitting radiation did not reduce survival in CNS lymphoma
• Overweight, obese women less likely to respond to assisted reproductive technology
• Patients with CML had increased risk for secondary malignancies before introduction of imatinib treatment
• Patients with metastatic breast cancer may benefit from combination therapy with everolimus
• Radiation therapy reduced risk for breast cancer recurrence
• Sandoz, Parenta methotrexate injection recalled
• Screening for prostate cancer decreased risk for future metastatic disease
• Study enrollment stopped due to improved PFS
• Superior survival seen in MUTYH-associated polyposis colorectal cancer
• Telomere length may affect colorectal cancer risk
• Vitamin D insufficiency associated with faster progression, poorer survival in CLL
• WHO hand hygiene framework easy to implement
• Carcinoid tumor and bowel obstruction Varsha Vimalananda, MD
• Verifying data to make the right decisions William Wood, MD
• Bevacizumab plus fotemustine may be first-line option for advanced melanoma patients
• IV bisphosphonates associated with increased risk for stroke, atrial fibrillation in older patients with cancer
• Total duration of treatment associated with local, colostomy failure in anal cancer
• New colorectal screening test effectively measured precancers
• High-dose methotrexate therapy: Focus on glucarpidase Debbie Blamble, PharmD, BCOP